申请人:Schering Aktiengesellschaft
公开号:US04057640A1
公开(公告)日:1977-11-08
Carbazoles of the formula ##STR1## wherein R.sub.1 is hydroxymethyl, alkanoyloxymethyl, tetrazolyl, cyano, oximinocarbonyl, aminocarbonyl, carboxyl and salts thereof with physiologically acceptable bases and the esters thereof with physiologically acceptable alcohols and amides thereof with physiologically acceptable amines, R.sub.2 through R.sub.6 each are a hydrogen atom, halogen atom, lower alkyl, trifluoromethyl, or lower alkoxy, or R.sub.5 and R.sub.6 collectively are a five- or six-membered isocyclic ring, and R.sub.7 is a hydrocarbon of 3-8 carbon atoms or, when at least one of the R.sub.2 through R.sub.6 is other than a hydrogen atom, a hydrogen atom, methyl or ethyl, And the corresponding compounds wherein R.sub.7 is a hydrogen atom, methyl or ethyl, And the 5,6,7,8-tetrahydrocarbazoles, possess topical anti-inflammatory activity.
式为##STR1##的咔唑类化合物,其中R.sub.1是羟甲基、烷酰氧甲基、
四唑基、
氰基、
肟基甲酰基、
氨基甲酰基、羧基及其与生理上可接受的碱的盐以及其与生理上可接受的醇的酯和其与生理上可接受的胺的酰胺,R.sub.2到R.sub.6分别是氢原子、卤素原子、低碳基、三
氟甲基或低氧基,或R.sub.5和R.sub.6共同是五元或六元异环环,R.sub.7是3-8碳原子的碳氢化合物或当R.sub.2到R.sub.6中至少一个不是氢原子时,为氢原子、甲基或乙基。相应的化合物中,R.sub.7是氢原子、甲基或乙基,以及5,6,7,8-四氢
咔唑具有局部抗炎活性。